A urinary glucose assay has been investigated, employing a micro flow injection analysis (µFIA) combined with a separation technique of glucose from the analyte. The adsorption part using activated alumina for the glucose in the analyte can be successively integrated onto a µFI chip. The selective adsorption-desorption of glucose in the artificial urine can progress on the adsorption part. Along with this selective preconcentration of glucose, the typical FI peak of glucose can be obtained just by feeding the sample and deionized water as an elutant sandwiched with the reagent on the carrier stream. The glucose concentration in artificial urine can be quantitatively determined with the present µFIA system, while the interference of other components coexisting in urine occurs in the case of the conventional FIA system without any separation part. The described method serves as a template for improving the selectivity for the analyte in the multi-component system.
Introduction
The determination of glucose levels in biological samples is an indispensable test for the diagnosis and therapy of diabetes mellitus, hypoglycemia, and suspected meningitis. 1 The International Diabetes Federation estimates that 190 million sufferers exist worldwide, and this number is expected to reach 324 million by 2025. High performance liquid chromatography (HPLC) and gas chromatography (GC) have been used for the assay of glucose. However, these methods involve several complicated and time-consuming sample preparation steps. Flow injection analysis (FIA) has also been applied to the determination of glucose in an aqueous solution, especially using enzymatic methods with glucose oxidase (GOD) of spectrophotometry, 2,3 chemiluminescence, 4 amperometry, [5] [6] [7] [8] voltammetry, 9 and fluorometry. 10 Since oxygen is used as an oxidant for the enzymatic reaction in these methods, the dynamic range of the measurement is limited by the dissolved oxygen concentration.
For a glucose assay in human fluid using FIA, there might be interferences due to the various coexisting components. An electrochemical method is therefore mainly used for the determination of glucose in urine and blood, since this technique has the feature of selectivity for the analyte. Electrode analysis, however, still has a problem to be soiled during the continuous assays of human fluids.
The spectrophotometric assay has an advantage concerning maintenance during continuous assays, although less selectivity is possible for the analyte compared to that in the electrochemical determination. The separation of glucose from such components is necessary to be achieved prior to the spectrophotometric assay of glucose in human fluids. The conventional FIA technique on-lined with separation and preconcentration, with mini-columns containing an appropriate adsorbent, has been extensively used to increase the sensitivity and selectivity in the analytical determination. 11 This method offers some favorable features, such as low reagent and sample consumption, better efficiency and reproducibility, higher sample throughput, lesser risk of contamination, and also simple automated operation. Activated alumina, a traditional ionexchange adsorbent, seems to be attractive for glucose separation, 12, 13 since it displays a high affinity for a wide range of cationic species under basic conditions, while exhibiting a high affinity for anions under acidic conditions. 14 The analytical instruments for urinary glucose are recently demanded to be portable with a simple analytical protocol, not only to check the urinary glucose level for diabetics, but also for the health care of healthy persons at home. Miniaturization of flow-based assays is at present an actively pursued topic in analysis research, along with improving of the precise machining techniques. The concept of the micro total analysis system (µTAS), using a unit operations integrated micro chip (lab-on-a-chip), has been proposed. 15 Recently, sequential injection analysis (SIA) has been developed, as the second generation of FIA, for miniaturizing the instrument. 16, 17 The size of the SIA system, however, is not small enough for a portable instrument, since it aims to determine many kinds of analytes on the same platform only by selecting the protocol. The miniaturization of the FIA system by concentrating upon each assay has been decided to be suitable from the view point In the present work, a µFIA system for the urinary glucose assay, based on the spectrophotometric determination, is investigated. The µFIA was fabricated on a poly(methyl methacrylate) (PMMA) plate, and a suitable protocol for a glucose assay was investigated. The separation part of glucose from other components in urine, with activated alumina, was then combined with µFIA to prevent their interaction on the assay. Finally, the potential of the µFIA system developed was evaluated.
Experimental

Reagents and solutions
Human pooled serum (CELLectR) was supplied by ICN Biomedicals and human hemoglobin was supplied by Sigma as lyophilized powder. All other chemicals used were supplied by Wako Pure Chemical Industries, as analytical-grade reagents. The chemicals were used without further purification. All solutions were prepared with deionized water purified with a Milli-Q PLUS system (Millipore). Glucose CII-Test Wako, including phosphoric acid, glucose oxidase, mutarotase, peroxidase, 4-aminoantipyrine, phenol, and ascorbate oxidase, was used as the determination reagent. A stock solution of glucose (500 mg/dL) was prepared by dissolving 2.500 g of α-D-glucose (Wako Pure Chemical Industries, Ltd.) in 500 mL of deionized water, and sample solutions of glucose were prepared by suitable dilution. Artificial urine was prepared to investigate the interference of other components. The contents of the artificial urine are listed in Table 1 . Activated alumina used as an adsorbent for the glucose is a particle size of 90 µm, a pH value of 9.0 -11.0, and a density of 0.8 g/mL.
Fabrication of micro flow injection chip
The micro FI chip was made on PMMA plate using a tabletype NC detailed processing machine (PMT Corporation Co., Ltd.). First, the micro flow channel was designed with CAD software, and then a channel was dug with a 0.5 mm square end mill. The micro channel was fabricated on a PMMA plate of 5 mm thickness, and a channel for a fiber spectrophotometer (φ = 1.8 mm) was fabricated in the PMMA plate with 15 mm thickness. The end point of the micro channel and the channel for an optical fiber-type spectrophotometer was connected with another vertical channel. The two PMMA plates were then adhered in a constant-temperature oven at 120˚C. In the present work, two kinds of the µFI cells, both with and without a glucose-separation part, were fabricated. Figure 1 shows a schematic diagram of the FIA system. In the case of the µFIA system with the glucose-separation part, adsorption part of 5 or 10 mm in length, 2 mm in width, and 2 mm in depth was fabricated on the chip, and activated alumina was filled and sandwiched by glass wool. After three months of operation, no significant variation on of the alumina efficiency was verified.
Procedures
The enzymatic reaction of glucose with the reagent takes place in an aqueous medium, as shown in Scheme 1. The recommended batch protocol of this enzyme reaction is that the absorbance at 505 nm is measured after 20 µL of the sample solution and 3.0 mL of the reagent are mixed and reacted for 15 min at room temperature. It actually takes about 400 s to achieve the 100 ANALYTICAL SCIENCES JANUARY 2006, VOL. 22 maximum absorbance. In the case of the µFIA system, the inlet of the µFI chip and a programmable syringe pump (Harvard, MODEL 11 or MODEL 11-IW) were connected with small-bore (0.50 mm i.d.) polytetrafluoroethylene (PTFE) tubing, via a sixposition valve (Rheodyne Co., Model 9060). The carrier, sample, reagent and deionized water as an elutant were sequentially dispensed into the µFI chip using the six-position valve at 100 µL/min. Spectrophotometric measurements were carried out at 505 nm using an Ocean Optics UV-VIS spectrometer (USB2000, Ocean Optics Inc.). Fiber-optic cables furnished with a stainless-steel clad tip (400 µm i.d.) were used to connect the flow cell to the light source and the spectrometer. Each analysis was repeated six times to obtain calibration curves by using the average of the peak top value of the absorbance at 505 nm against the reference absorbance of deionized water. A pH meter (F-23, Horiba) was used to determine the pH of solutions. All experiments were carried out at room temperature (25˚C).
Results and Discussion
µFIA system without separation The µFIA system allows decreasing sample and reagent consumption and a shortening of the time for each assay. Considering the decrease of reagent consumption, the use of water as a carrier solution is comprehensive. Optimization of the protocol for a single glucose assay was first carried out using the µFI system without a separation part. Figure 2(a) shows the calibration curve obtained by the protocol that 3.33 µL of sample and 13.3 µL of the reagent were sequentially dispensed towards the detector. Although a linear relationship between the glucose concentration and the absorbance at 505 nm (A505) was obtained with Y = 2.32 × 10 -3 X + 2.52 × 10 -2 (r 2 = 0.982, 0 -75 mg/dL), the reproducibility and the correlation coefficient were insufficient. This suggests that stable mixing between the sample and the reagent zones was incomplete. An alternative protocol to improve of zone mixing is that the sample zone is sandwiched within the reagents. X + 2.21 × 10 -2 (r 2 = 0.990, 0 -75 mg/dL). The limit of detection (LOD) value, which is defined as the ratio of three times the standard deviation of the background signal to the slope of the calibration curve, can be obtained to be 2.93 mg/dL. In addition, since the FI peak was obtained within 50 s in the case of Fig. 2(b) , the analysis time can be improved by about 8-times faster than that with the batchwise method. The limitation of the linear relationship of the calibration curve may be caused by incomplete reaction between the glucose and the reagent at the detection part.
Artificial urine was then applied to this system to determine the glucose concentration. Although artificial urine contains 80.0 mg/dL of glucose, a much lower concentration of 34.9 mg/dL was detected by the above protocol. This is because of the interference with other components in the artificial urine, suggesting that the separation of glucose from other urinary components would be necessary prior to detection.
µFIA system combined with separation
The adsorptive separation of glucose onto activated alumina was combined with the µFIA. In a preliminary study using the conventional batch and column separation experiment, activated alumina had a high adsorption ability of glucose, which was scarcely effected by the pH (ca. 3 -11) and the flow rate. In addition, the adsorbed glucose could be easily eluted with water. The µFIA system combined with the adsorptive separation of glucose was first fabricated to investigate the effect of the volume of the adsorption part. The reagent was used as a carrier, and a single glucose solution (sample) and water (elutant) were sequentially dispensed towards the detector. In this case, two kinds of sample volumes and two kinds of adsorption cell sizes were constructed. Figure 3 (a) shows the FI peak obtained with 5 mm of the micro adsorption cell, when 3.33 µL of the sample and 3.33 µL of deionized water (elutant) were dispensed. The typical FI peak was obtained, indicating that the adsorbed glucose was successively eluted with water. A similar shape of the peak was obtained by using a 10 mm micro adsorption part. When 6.67 µL of the sample was used, a similar peak shape was also obtained in the case of the 5 mm adsorption part, while an additional shoulder peak appeared in the case of the 10 mm adsorption part, as shown in Fig. 3(b) . This may have been caused because the sample zone became to split during the 101 ANALYTICAL SCIENCES JANUARY 2006, VOL. 22 adsorption-desorption process. A sample volume of 3.33 µL was therefore used in the following experiments. Figure 4 shows the calibration curve obtained with the protocol of Fig. 3(a) . The calibration curve was Y = 4.38 × 10 -3 X -5.56 × 10 -4 (r 2 = 0.992, 0 -100 mg/dL). The linear relationship range was extended up to 100 mg/dL, compared with the system without any separation part. Considering that the reagent is an aqueous solution, the reagent might be used as the elutant, as well as the water. A protocol without using water was therefore carried out, in which 3.33 µL of sample was just dispensed into the carrier stream of the reagent. An FI peak similar to Fig. 3(a) was also obtained, and a calibration curve of 0 -100 mg/dL was obtained. However, the linearity became worse (r 2 = 0.988). This may be because the quantitative desorption of glucose from aluminum is difficult to achieve.
A reduction of reagent consumption was then conducted by changing the carrier solution from the reagent to deionized water. A water zone of 3.33 µL was dispensed, followed by a sample zone of 3.33 µL, to elute the glucose from the adsorbent. That is, these two zones were sandwiched with the reagent zones (8.33 µL and 25.0 µL). Figure 5 shows the peak shape and the calibration curve obtained by using the µFIA system with a 5 mm separation part with the above mentioned protocol. A linear relationship up to 100 mg/dL (Y = 2.40 × 10 -3 X + 9.10 × 10 -3
; r 2 = 0.997) with a LOD value of 1.29 mg/dL was obtained, although the absorbance and the sensitivity decreased due to the decrease in the amount of reagent. In order to improve the linearity range, several conditions were improved. The range could be extended by changing the volume of the adsorption part. When the same protocol of Fig. 3(a) and Fig. 4 was applied to the µFIA system with the separation part of 10 mm, no shoulder peak appeared, and a linear relationship was obtained until 150 mg/dL (Y = 3.82 × 10 -3 X + 3.72 × 10 -2 ; r 2 = 0.986, 0 -150 mg/dL). Sample dilution seemed to progress on the adsorption part during the adsorption-desorption process. On the other hand, when the water was used as a carrier solution, and the same protocol of Fig. 5 was applied, a linear relationship was obtained until just 100 mg/dL. This may have been due to a lack of reagent amount, since the sample zone was diffused and prolonged due to the adsorption-desorption process. A linear relationship up to 150 mg/dL was therefore obtained by using a greater amount of the reagent, i.e., the stacked zones were 16.7 µL of the reagent, 3.33 µL of the sample, 3.33 µL of water, and 33.3 µL of the reagent. In this case, a calibration curve of Y = 3.21 × 10 -3 X + 7.40 × 10 -3 (r 2 = 0.995, 0 -150 mg/dL) could be obtained.
Determination of urinary glucose in the artificial urine
The potential of combining the separation system into the µFIA system was examined. The effect of the pH of the sample solution was first investigated. Figure 6 shows the absorbance at 505 nm of the peak of an 80 mg/dL sample, by using the protocol shown in Fig. 5 . There was no significant effect of the pH value from 4 to 10, although the optimum pH value of 4.5 was reported in the case of voltammetry using GOD. 18 The present method, therefore, has an advantage that a pH treatment of the sample is unnecessary, because the normal pH range of human urine is from 5.0 to 7.4. The proposed µFIA system was then applied to multicomponent samples. When 3.33 µL of artificial urine and 80 mg/dL of glucose were used as a sample, a concentration of 85.3 mg/dL (RSD = 4.51, n = 6, RSD is based on the concentration) was obtained. In the case when the artificial urine was diluted with the same volume of water, the concentration determined in the solution was 42.8 mg/dL (RSD = 2.71, n = 6). Therefore, interference with other components in the artificial urine could be avoided, and an appropriate concentration of glucose in the multi-component system could be obtained with the proposed µFIA system. In addition, because the whole FI peak was obtained for 150 s (Fig. 5) , an analyzing frequency of ca. 20 samples/h could be obtained when the sample and reagent loading is taken into account. The µFIA system developed in the present work therefore shows a powerful potential for the selectivity of the analyte, which is one of the disadvantages of spectrophotometry, and that accurate analysis with good reproducibility can be carried out with a high sampling rate.
Conclusion
A µFIA system combined with the separation part for the analyte has been investigated, with the following results. The µFIA system with a separation part using activated alumina could be fabricated on a PMMA chip, and precise handling 102 ANALYTICAL SCIENCES JANUARY 2006, VOL. 22 Fig. 4 Calibration curve obtained from the protocol of Fig. 3 (a) . could be performed. The glucose in the sample solution was firstly adsorbed on activated alumina and eluted with water, and then the FI peak could be successively obtained. The determination of glucose in artificial urine containing 6 other components could be quantitatively determined with the present system. The present system could reduce the use of a reagent to 33.3 µL/sample, which is a ca. 90-fold reduction compared to the batchwise analysis. A sampling rate of 20 samples/h could be obtained by the protocol presented in this work. This µFIA approach combined with a separation technique has improved the quantitative analysis of glucose in urine, without only complicated pretreatment of the sample.
